Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India
Authors:
- Sanjay KalraSKSanjay Kalra
- Jubbin JacobJJJubbin Jacob
- A. G. UnnikrishnanAUA. G. Unnikrishnan
- Ganapathi BantwalGBGanapathi Bantwal
- Abhay SahooASAbhay Sahoo
- Rakesh SahayRSRakesh Sahay
- Sushil JindalSJSushil Jindal
- Madhu Sudan AgrawalMAMadhu Sudan Agrawal
- Nitin KapoorNKNitin Kapoor
- Banshi SabooBSBanshi Saboo
- Mangesh TiwaskarMangesh Tiwaskar
- Kapil KochharKKKapil Kochhar
Open Access
- 22 February 2023
- journal article
- review article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2023, 1-10
Abstract
Male hypogonadism (MH) is a clinical and biochemical syndrome caused by inadequate synthesis of testosterone. Untreated MH can result in long-term effects, including metabolic, musculoskeletal, mood-related, and reproductive dysfunction. Among Indian men above 40years of age, the prevalence of MH is 2029. Among men with type 2 diabetes mellitus, 20.7 are found to have hypogonadism. However, due to suboptimal patient-physician communication, MH remains heavily underdiagnosed. For patients with confirmed hypogonadism (either primary or secondary testicular failure), testosterone replacement therapy (TRT) is recommended. Although various formulations exist, optimal TRT remains a considerable challenge as patients often need individually tailored therapeutic strategies. Other challenges include the absence of standardized guidelines on MH for the Indian population, inadequate physician education on MH diagnosis and referral to endocrinologists, and a lack of patient awareness of the long-term effects of MH in relation to comorbidities. Five nationwide advisory board meetings were convened to garner expert opinions on diagnosis, investigations, and available treatment options for MH, as well as the need for a person-centered approach. Experts opinions have been formulated into a consensus document with the aim of improving the screening, diagnosis, and therapy of men living with hypogonadism.Keywords
This publication has 37 references indexed in Scilit:
- Performance of Total Testosterone Measurement to Predict Free Testosterone for the Biochemical Evaluation of Male HypogonadismJournal of Urology, 2012
- Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement TherapyInternational Journal of Endocrinology, 2012
- Testosterone DeficiencyThe American Journal of Medicine, 2011
- Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney diseaseNephrology Dialysis Transplantation, 2011
- Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset HypogonadismKorean Journal of Urology, 2011
- Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly MenNew England Journal of Medicine, 2010
- A cross-sectional pilot study to determine the prevalence of testosterone deficiency syndrome in working population of Indian menIndian Journal of Urology, 2009
- Investigation, treatment and monitoring of late-onset hypogonadism in malesEuropean Journal of Endocrinology, 2008
- Idiopathic or Hypogonadal Osteoporosis in MenTreatments in Endocrinology, 2004
- The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunctionInternational Journal Of Impotence Research, 2002